Table of Contents
ISRN Endocrinology
Volume 2013 (2013), Article ID 867938, 7 pages
http://dx.doi.org/10.1155/2013/867938
Research Article

Placental HSD2 Expression and Activity Is Unaffected by Maternal Protein Consumption or Gender in C57BL/6 Mice

1Department of Biology, Winona State University, 234 Pasteur Hall, P.O. Box 5838, Winona, MN 55987, USA
2Department of Pediatrics, 5111 DOT, Vanderbilt Children’s Hospital, Vanderbilt University, Nashville, TN 37232, USA

Received 3 April 2013; Accepted 30 April 2013

Academic Editors: J. Pachucki, H.-Q. Qu, and G. Wittmann

Copyright © 2013 Mark R. Garbrecht and Fred S. Lamb. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. C. McMillen and J. S. Robinson, “Developmental origins of the metabolic syndrome: prediction, plasticity, and programming,” Physiological Reviews, vol. 85, no. 2, pp. 571–633, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. C. Langley-Evans, “Fetal programming of cardiovascular function through exposure to maternal undernutrition,” Proceedings of the Nutrition Society, vol. 60, no. 4, pp. 505–513, 2001. View at Google Scholar · View at Scopus
  3. M. J. Meaney, M. Szyf, and J. R. Seckl, “Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health,” Trends in Molecular Medicine, vol. 13, no. 7, pp. 269–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. C. Langley-Evans, G. J. Phillips, R. Benediktsson et al., “Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat,” Placenta, vol. 17, no. 2-3, pp. 169–172, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Krozowski, K. X. Z. Li, K. Koyama et al., “The type I and type II 11β-hydroxysteroid dehydrogenase enzymes,” Journal of Steroid Biochemistry and Molecular Biology, vol. 69, no. 1–6, pp. 391–401, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Seckl, “Prenatal glucocorticoids and long-term programming,” European Journal of Endocrinology, Supplement, vol. 151, supplement 3, pp. U49–U62, 2004. View at Google Scholar · View at Scopus
  7. C. Bertram, A. R. Trowern, N. Copin, A. A. Jackson, and C. B. Whorwood, “The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11β-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero,” Endocrinology, vol. 142, no. 7, pp. 2841–2853, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Langley-Evans, S. J. M. Welham, R. C. Sherman, and A. A. Jackson, “Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension,” Clinical Science, vol. 91, no. 5, pp. 607–615, 1996. View at Google Scholar · View at Scopus
  9. N. S. Levitt, R. S. Lindsay, M. C. Holmes, and J. R. Seckl, “Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat,” Neuroendocrinology, vol. 64, no. 6, pp. 412–418, 1996. View at Google Scholar · View at Scopus
  10. R. D. Roghair, J. L. Segar, K. A. Volk et al., “Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice,” American Journal of Physiology, vol. 296, no. 3, pp. R651–R662, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. D. Roghair, J. L. Segar, R. A. Kilpatrick, E. M. Segar, T. D. Scholz, and F. S. Lamb, “Murine aortic reactivity is programmed equally by maternal low protein diet or late gestation dexamethasone,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 20, no. 11, pp. 833–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. R. Garbrecht, J. M. Klein, T. A. McCarthy, T. J. Schmidt, Z. S. Krozowski, and J. M. Snyder, “11-β Hydroxysteroid dehydrogenase type 2 in human adult and fetal lung and its regulation by sex steroids,” Pediatric Research, vol. 62, no. 1, pp. 26–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Clapcote and J. C. Roder, “Simplex PCR assay for sex determination in mice,” BioTechniques, vol. 38, no. 5, pp. 702–706, 2005. View at Google Scholar · View at Scopus
  14. M. R. Garbrecht, Z. S. Krozowski, J. M. Snyder, and T. J. Schmidt, “Reduction of glucocorticoid receptor ligand binding by the 11-β hydroxysteroid dehydrogenase type 2 inhibitor, Thiram,” Steroids, vol. 71, no. 10, pp. 895–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. G. Atanasov, S. Tam, J. M. Röcken, M. E. Baker, and A. Odermatt, “Inhibition of 11β-hydroxysteroid dehydrogenase type 2 by dithiocarbamates,” Biochemical and Biophysical Research Communications, vol. 308, no. 2, pp. 257–262, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. E. P. Gomez-Sanchez, V. Ganjam, Y. J. Chen, Y. Liu, S. A. Clark, and C. E. Gomez-Sanchez, “The 11β hydroxysteroid dehydrogenase 2 exists as an inactive dimer,” Steroids, vol. 66, no. 11, pp. 845–848, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. V. E. Murphy, P. G. Gibson, W. B. Giles et al., “Maternal asthma is associated with reduced female fetal growth,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 11, pp. 1317–1323, 2003. View at Publisher · View at Google Scholar
  18. K. M. Moritz, J. S. M. Cuffe, L. B. Wilson et al., “Review: sex specific programming: a critical role for the renal renin-angiotensin system,” Placenta, supplement 31, pp. S40–S46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. O'Donnell, A. Bugge Jensen, L. Freeman, N. Khalife, T. G. O'Connor, and V. Glover, “Maternal prenatal anxiety and downregulation of placental 11β-HSD2,” Psychoneuroendocrinology, vol. 37, no. 6, pp. 818–826, 2012. View at Google Scholar
  20. S. C. Langley-Evans, “Fetal programming of cardiovascular function through exposure to maternal undernutrition,” Proceedings of the Nutrition Society, vol. 60, no. 4, pp. 505–513, 2001. View at Google Scholar · View at Scopus
  21. B. S. Knight, C. E. Pennell, R. Shah, and S. J. Lye, “Strain differences in the impact of dietary restriction on fetal growth and pregnancy in mice,” Reproductive Sciences, vol. 14, no. 1, pp. 81–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. R. Seckl and M. C. Holmes, “Mechanisms of disease: glucocorticoids, their placental metabolism and fetal “programming” of adult pathophysiology,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 6, pp. 479–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Brawley, S. Itoh, C. Torrens et al., “Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring,” Pediatric Research, vol. 54, no. 1, pp. 83–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Nyirenda, R. S. Lindsay, C. J. Kenyon, A. Burchell, and J. R. Seckl, “Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring,” Journal of Clinical Investigation, vol. 101, no. 10, pp. 2174–2181, 1998. View at Google Scholar · View at Scopus
  25. N. M. Long, D. R. Shasa, S. P. Ford, and P. W. Nathanielsz, “Growth and insulin dynamics in two generations of female offspring of mothers receiving a single course of synthetic glucocorticoids,” American Journal of Obstetrics and Gynecology, vol. 207, no. 3, pp. 203.e1–203.e8, 2012. View at Google Scholar
  26. R. D. Roghair, F. S. Lamb, F. J. Miller Jr., T. D. Scholz, and J. L. Segar, “Early gestation dexamethasone programs enhanced postnatal ovine coronary artery vascular reactivity,” American Journal of Physiology, vol. 288, no. 1, pp. R46–R53, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. E. C. Cottrell, M. C. Holmes, D. E. Livingstone, C. J. Kenyon, and J. R. Seckl, “Reconciling the nutritional and glucocorticoid hypotheses of fetal programming,” FASEB Journal, vol. 26, no. 5, pp. 1866–1874, 2012. View at Google Scholar
  28. A. Thompson, V. K. M. Han, and K. Yang, “Spatial and temporal patterns of expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 messenger RNA and glucocorticoid receptor protein in the murine placenta and uterus during late pregnancy,” Biology of Reproduction, vol. 67, no. 6, pp. 1708–1718, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Behravan and M. Piquette-Miller, “Drug transport across the placenta, role of the ABC drug efflux transporters,” Expert Opinion on Drug Metabolism and Toxicology, vol. 3, no. 6, pp. 819–830, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. G. M. Kalabis, A. Kostaki, M. H. Andrews, S. Petropoulos, W. Gibb, and S. G. Matthews, “Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection,” Biology of Reproduction, vol. 73, no. 4, pp. 591–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Parry and J. Zhang, “Multidrug resistance proteins affect drug transmission across the placenta,” American Journal of Obstetrics and Gynecology, vol. 196, no. 5, pp. 476.e1–476.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus